AbbVie Declares Quarterly Dividend

AbbVie (NYSE: ABBV) has announced a quarterly cash dividend of $1.64 per share, payable on August 15, 2025, to stockholders of record as of July 15, 2025.

Rhea-AI Summary

AbbVie (NYSE: ABBV) has announced a quarterly cash dividend of $1.64 per share, payable on August 15, 2025, to stockholders of record as of July 15, 2025. The pharmaceutical company has demonstrated strong commitment to shareholder returns, increasing its dividend by 310 percent since its establishment in 2013. AbbVie's consistent dividend growth has earned it a place in the prestigious S&P Dividend Aristocrats Index, which includes companies that have raised their dividends for at least 25 consecutive years.

Positive

• Quarterly dividend of $1.64 per share maintains consistent shareholder returns
• Impressive 310% dividend growth since 2013 demonstrates strong financial performance
• Inclusion in S&P Dividend Aristocrats Index reflects reliable dividend growth history

Negative

• None.

News Market Reaction – ABBV

-0.10%

-0.10% Session move

In the trading session that priced this news, ABBV declined 0.10%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NORTH CHICAGO, Ill., June 20, 2025 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.64 per share. 

The cash dividend is payable August 15, 2025, to stockholders of record at the close of business on July 15, 2025.

Since the company's inception in 2013, AbbVie has increased its dividend by 310 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology, neuroscience and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter) and YouTube.

Media:	Investors:
Gabby Tarbert	Liz Shea
(224) 244-0111	(847) 935-2211
gabrielle.tarbert@abbvie.com	liz.shea@abbvie.com

 

View original content:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-302486685.html

SOURCE AbbVie

FAQ

What is AbbVie's (ABBV) quarterly dividend payment for Q3 2025?

AbbVie's quarterly dividend payment for Q3 2025 is $1.64 per share, payable on August 15, 2025, to stockholders of record as of July 15, 2025.

How much has AbbVie's dividend increased since 2013?

AbbVie has increased its dividend by 310 percent since its inception in 2013.

When is the record date for AbbVie's Q3 2025 dividend?

The record date for AbbVie's Q3 2025 dividend is July 15, 2025.

Is AbbVie (ABBV) a Dividend Aristocrat?

Yes, AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have increased their dividend annually for at least 25 consecutive years.